Local Institution

Charlottesville, Virginia 22908

0 studies enrolling now · 12 studies all time

What they study most

Alcoholism, Alzheimer Disease, Bipolar I Disorder, Breast Cancer, Cancer, Hypertension, Kawasaki Disease, Lupus Nephritis, Major Depressive Disorder, Melanoma

Studies at this site

• Pan Tumor Rollover Study — Recruiting now
• Neoadjuvant Nivolumab+Ipilimumab Followed by Adjuvant Nivolumab or Neoadjuvant Nivolumab+Ipilimumab Followed by Adjuvant Observation Compared With Adjuvant Nivolumab in Treatment-Naive High-risk Melanoma Participants — Withdrawn before enrolling
• Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis — Stopped early
• Epothilone (Ixabepilone) Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer — Completed
• A Study to Evaluate the Use and Safety of CARDIOLITE® in Pediatric Patients With Kawasaki Disease — Completed
• A Study of Adjunctive Aripiprazole in Patients With Major Depressive Disorder — Completed
• Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of the Alzheimer's Type — Completed
• Study of Aripiprazole in Subjects With Alcoholism — Completed
• A Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depressive Episode — Completed
• A Long-Term Study of Aripiprazole in Patients With Major Depressive Disorder — Completed
• Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy for Patients With Moderate Hypertension — Completed
• Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy as First Line Treatment for Severe Hypertension — Completed